Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Point of Care Molecular Diagnostics Market, by Product & Service
1.4.2 North America Point of Care Molecular Diagnostics Market, by End User
1.4.3 North America Point of Care Molecular Diagnostics Market, by Technology
1.4.4 North America Point of Care Molecular Diagnostics Market, by Application
1.4.5 North America Point of Care Molecular Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. North America Point of Care Molecular Diagnostics Market by Product & Service
4.1 North America Assays & Kits Market by Country
4.2 North America Instruments & Analyzers Market by Country
4.3 North America Software & Services Market by Country
Chapter 5. North America Point of Care Molecular Diagnostics Market by End User
5.1 North America Physicians Offices Market by Country
5.2 North America Hospitals & ICUs Market by Country
5.3 North America Research Institutes Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Point of Care Molecular Diagnostics Market by Technology
6.1 North America RT-PCR Market by Country
6.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Point of Care Molecular Diagnostics Market by Application
7.1 North America Respiratory Diseases Market by Country
7.2 North America Hospital-acquired Infections Market by Country
7.3 North America Sexually Transmitted Diseases Market by Country
7.4 North America Cancer Market by Country
7.5 North America Hepatitis Market by Country
7.6 North America Gastrointestinal Disorders Market by Country
7.7 North America Others Market by Country
Chapter 8. North America Point of Care Molecular Diagnostics Market by Country
8.1 US Point of Care Molecular Diagnostics Market
8.1.1 US Point of Care Molecular Diagnostics Market by Product & Service
8.1.2 US Point of Care Molecular Diagnostics Market by End User
8.1.3 US Point of Care Molecular Diagnostics Market by Technology
8.1.4 US Point of Care Molecular Diagnostics Market by Application
8.2 Canada Point of Care Molecular Diagnostics Market
8.2.1 Canada Point of Care Molecular Diagnostics Market by Product & Service
8.2.2 Canada Point of Care Molecular Diagnostics Market by End User
8.2.3 Canada Point of Care Molecular Diagnostics Market by Technology
8.2.4 Canada Point of Care Molecular Diagnostics Market by Application
8.3 Mexico Point of Care Molecular Diagnostics Market
8.3.1 Mexico Point of Care Molecular Diagnostics Market by Product & Service
8.3.2 Mexico Point of Care Molecular Diagnostics Market by End User
8.3.3 Mexico Point of Care Molecular Diagnostics Market by Technology
8.3.4 Mexico Point of Care Molecular Diagnostics Market by Application
8.4 Rest of North America Point of Care Molecular Diagnostics Market
8.4.1 Rest of North America Point of Care Molecular Diagnostics Market by Product & Service
8.4.2 Rest of North America Point of Care Molecular Diagnostics Market by End User
8.4.3 Rest of North America Point of Care Molecular Diagnostics Market by Technology
8.4.4 Rest of North America Point of Care Molecular Diagnostics Market by Application
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Bayer AG
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 Thermo Fisher Scientific, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 BioMerieux S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.6 Qiagen N.V.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 Bio-Rad laboratories, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Acquisition and Mergers:
9.9 Agilent Technologies, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.10. Nova Biomedical Corporation
9.10.1 Company Overview
Unique Offerings 
